GlassScriptPhysician profile
Wingkan W Sbar
NPI 1265648349
$1,988.17
in general payments reported to CMS, 2019-2025
20 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $994 · 2022: $120 · 2023: $244 · 2024: $136 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $1,009.75 | 2019-2020 | |
| Exeltis, USA INC. | $160.15 | 2019-2025 | Slynd |
| Abbvie INC. | $116.78 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $106.72 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Astellas Pharma US INC | $96.88 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $65.95 | 2022-2023 | |
| Lupin INC. | $54.62 | 2019 | |
| Organon LLC | $53.26 | 2022-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $42.76 | 2022-2024 | |
| Therapeuticsmd, INC. | $42.21 | 2019-2020 | |
| Smith+Nephew, INC. | $35.60 | 2024 | Pico 7 |
| Millicent US INC | $33.71 | 2019-2025 | Femlyv |
| Duchesnay USA Incorporated | $29.33 | 2019 | |
| Allergan, INC. | $28.80 | 2019 | |
| Evofem Biosciences, INC. | $28.48 | 2023-2024 | Phexxi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $22.64 | 2025 | Sos |
| Amag Pharmaceuticals, INC. | $17.25 | 2019 | |
| Sumitomo Pharma America, INC. | $15.46 | 2025 | Myfembree |
| Agile Therapeutics, INC. | $15.00 | 2022 | |
| Pfizer INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wingkan Sbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.